Retooled two-midnight rule gets mixed reviews

Retooled two-midnight rule gets mixed reviews

Providers and policy experts are split on the Obama administration's proposal to salvage the controversial two-midnight rule with a series of modifications intended to mollify its many critics. Some influential stakeholders still want it killed.

Medicare Advantage plans to test value-based insurance design

By Bob Herman  |  September 01, 2015

The CMS Innovation Center unveiled a new demonstration program Tuesday that will allow Medicare Advantage insurers to encourage the use of clinically valuable services by lowering out-of-pocket costs for enrollees.

Whistle-blower in $320 million SCAN case not entitled to cash

By Lisa Schencker  |  August 31, 2015

The whistle-blower whose case led to a whopping $320 million settlement between the government and SCAN Health Plan in 2012 is not entitled to any of that cash, a federal judge has ruled. Some say the decision could lead to fewer whistle-blowers bringing cases against Medicare Advantage plans.


Biotechnology companies, 2015

Biotechnology companies, 2015

A list of the 20 largest biotechnology companies ranked by 12-month revenue as of June 30, 2015. Source: BioPharm Insight. Published Aug. 31, 2015, p. 35.


Capella completes $900 million sale to REIT

Capella Healthcare, the privately held, Franklin, Tenn.-based chain, Tuesday announced it has finalized its $900 million sale to a real estate investment trust. In the deal, Medical Properties Trust acquires Capella's properties and a minority ownership in operations.

Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.